MENLO PARK, Calif.--(BUSINESS WIRE)--KKR, a leading global investment firm, and Duke Rohlen, a 20-year medical device veteran, today announced the formation of Zeus Health (“Zeus”), a $100 million platform focused on investing in and operating a portfolio of emerging medical device companies. Zeus marks the continuation of a long-standing relationship between KKR and Mr. Rohlen. Throughout his career, Mr. Rohlen has successfully led, grown and exited multiple medical device companies, including.